BioSyent Revenue

In the year 2024, BioSyent had annual revenue of 35.03M CAD with 10.89% growth. BioSyent had revenue of 8.80M in the quarter ending December 31, 2024, with 6.32% growth.

Revenue

35.03M

Revenue Growth

+10.89%

P/S Ratio

3.69

Revenue / Employee

n/a

Employees

n/a

Market Cap

125.58M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	35.03M	3.44M	10.89%
Dec 31, 2023	31.59M	3.67M	13.12%
Dec 31, 2022	27.93M	-693.03K	-2.42%
Dec 31, 2021	28.62M	6.29M	28.15%
Dec 31, 2020	22.33M	907.84K	4.24%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Green Thumb Industries	1.64B
dentalcorp Holdings	1.55B
Sienna Senior Living	893.16M
WELL Health Technologies	957.69M
Extendicare	1.47B
Curaleaf Holdings	1.93B
Trulieve Cannabis	1.71B
Cronos Group	169.23M

Revenue Rankings

BioSyent News

13 days ago - BioSyent Announces Grant of Restricted Share Units - GlobeNewsWire
17 days ago - BioSyent Inc. (BIOYF) Q4 2024 Earnings Call Transcript - Seeking Alpha
17 days ago - BioSyent reports Q4 results - Seeking Alpha
18 days ago - BioSyent Releases Financial Results for Fourth Quarter and Full Year 2024 - GlobeNewsWire
24 days ago - BioSyent Schedules Fourth Quarter and Full Year 2024 Earnings Release for March 13, 2025 - GlobeNewsWire
2 months ago - BioSyent declares CAD 0.05 dividend - Seeking Alpha
2 months ago - BioSyent Declares First Quarter 2025 Dividend - GlobeNewsWire
2 months ago - FAX Capital Files Early Warning Report Regarding Disposition of Common Shares of BioSyent Inc. - GlobeNewsWire

More News